Paragraph 2 C1

England and Wales

(1)

The Secretary of State may make regulations allowing F1NHS EnglandF2... to designate—

F3(a)

relevant areas,

(b)

premises, or

(c)

descriptions of premises,

for the purposes of this paragraph.

(2)

The regulations may, in particular, make provision—

(a)

as to the circumstances in which, and the F4relevant areas or premises in relation to which, designations may be made or maintained,

(b)

allowing NHS England to defer consideration of pharmaceutical list applications relating to relevant areas, premises or descriptions of premises that have been designated,

(c)

allowing a designation to be cancelled in prescribed circumstances,

(d)

requiring a designation to be cancelled—

(i)

if the Secretary of State gives a direction to that effect, or

(ii)

in prescribed circumstances.

(3)

“Pharmaceutical list applications” means applications for inclusion in a pharmaceutical list.

F5(4)

“Relevant area” has the same meaning as in section 129(2A).

Annotations

Textual amendments

F1: Words in Act substituted (1.7.2022) by Health and Care Act 2022 (c. 31), s. 186(6), Sch. 1 para. 1(1)(2); S.I. 2022/734, reg. 2(a), Sch. (with regs. 13, 29, 30)
F2: Words in Sch. 12 para. 2(1) omitted (1.4.2013) by virtue of Health and Social Care Act 2012 (c. 7), s. 306(4), Sch. 4 para. 93(3)(b) (with Sch. 4 para. 93(6)); S.I. 2013/160, art. 2(2) (with arts. 7-9)
F3: Words in Sch. 12 para. 2(1)(a) substituted (27.3.2012 for specified purposes, 1.4.2013 in so far as not already in force) by Health and Social Care Act 2012 (c. 7), ss. 207(12)(a), 306(1)(d)(4); S.I. 2013/160, art. 2(2) (with arts. 7-9)
F4: Words in Sch. 12 para. 2(2)(a)(b) substituted (27.3.2012 for specified purposes, 1.4.2013 in so far as not already in force) by Health and Social Care Act 2012 (c. 7), ss. 207(12)(a), 306(1)(d)(4); S.I. 2013/160, art. 2(2) (with arts. 7-9)
F5: Sch. 12 para. 2(4) inserted (27.3.2012 for specified purposes, 1.4.2013 in so far as not already in force) by Health and Social Care Act 2012 (c. 7), ss. 207(12)(b), 306(1)(d)(4); S.I. 2013/160, art. 2(2) (with arts. 7-9)

Modifications

C1: Sch. 12 para. 2 modified (1.4.2013) by The National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013 (S.I. 2013/349), regs. 1, 99(1)